buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet
RxNorm concept 1666338, clinical drug (scd).
- RxCUI
- 1666338
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1666338 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
buprenorphine (as buprenorphine hydrochloride) 2.9 MG / naloxone (as naloxone hydrochloride dihydrate) 0.71 MG Sublingual Tablet
Related concepts
- buprenorphine 2.9 MG (SCDC, consists of)
- naloxone 0.71 MG (SCDC, consists of)
- Sublingual Tablet (DF, has dose form)
- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet [Zubsolv] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1666338 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1666338 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1666338. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.